Compare Baroda BNP Paribas Health and Wellness Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.33
1.93
NAV
₹9.45
₹429.11
Fund Started
09 Jun 2025
04 Jun 1999
Fund Size
₹544.81 Cr
₹3822.73 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
8.54%
3 Year
-
25.98%
5 Year
-
17.17%
Equity
96.90%
98.53%
Cash
0.99%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.49% |
Mankind Pharma Ltd. | 7.41% |
Cipla Ltd. | 6.32% |
Max Healthcare Institute Ltd. | 5.80% |
Abbott India Ltd. | 4.96% |
Lupin Ltd. | 4.94% |
Torrent Pharmaceuticals Ltd. | 4.73% |
Aster DM Healthcare Ltd. | 4.56% |
Astrazeneca Pharma India Ltd. | 4.08% |
Ipca Laboratories Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
09 Jun 2025
04 Jun 1999
